The microbiome – a novel paradigm in oncology research

Editor's Choice for August 2018

New important compounds for targeted and immunotherapies for lung cancer

Updates from a range of lung cancer studies

Large B-cell lymphoma: ZUMA-1 trial

Five practice changing shifts in oncology

Treating myelodysplastic syndromes

Pharmacists and precision oncology

Involving pharmacists in oral oncology treatments

Two important pancreatic studies: PRODIGE 24 and PREOPANC

Rare mutations in non small cell lung cancer

The promise of immunotherapy in head and neck, and prostate cancer